Introduction
Cytokines regulate cell growth, differentiation and death. The interleukin-6 (IL-6) 1 family of cytokines (IL-6, leukemia inhibitory factor (LIF), oncostatin M, IL-11, ciliary neurotrophic factor and cardiotrophin-1) produce a variety of biological effects including the acute phase reaction associated with sepsis, and regulating the growth and differentiation of B cells including the growth of myeloma cells. 1 Each cytokine binds to a specific receptor ␣-subunit that then dimerizes with a common receptor ␤-subunit, gp130. 2 Dimerization of the receptor complex results in the activation of the gp130-associated Janus kinases and tyrosine phosphorylation of gp130. 3 Phosphorylated gp130 recruits signal-transducing molecules such as signal transducer and activator of transcription (STAT) 3 and protein tyrosine phosphatase 2, that in turn recruits the ERK MAP kinase. [4] [5] [6] Other non-receptor tyrosine kinases such as Btk, Tec and Hck are also activated following phosphorylation of gp130. 7, 8 Murine myeloid leukemia M1 cells cultured in the presence of IL-6 or LIF undergo terminal differentiation into macrophages associated with growth arrest. 9, 10 A number of genes have been identified whose levels of mRNA increase within 3 h of treatment of M1 cells with IL-6 or LIF. 11 The mRNA expression of these immediate response genes (IRF-1, JunB, Egr-1 and Gadd45) was induced in the presence of the protein synthesis inhibitor cycloheximide. Enforced expression of a number of these genes perturbed the growth and differentiation of M1 cells in response to Two types of IL-6 responsive elements have been identified in the genes encoding acute-phase reactants. The fibrinogen and haptoglobin genes were activated by the acute-phase response factor that was shown to be STAT3. 4, 5, 13 A second IL-6 responsive element present in C-reactive protein bound NF-IL6 that was shown to be CCAAT/enhancer binding protein ␣ (C/EBP ␣).
14 Other transcription factors implicated in the IL-6 or LIF response included NF-B and AP-1. 15, 16 It is clear, however, that regulation of immediate response genes is cell-type specific. For example, in HepG2 cells, induction of JunB required the combination of a low affinity STAT3 binding site and a cyclic AMP response element-like binding site. 17 In B cells, an NF-B binding site was important for IL-6 regulation. 18 In M1 cells, regulation of junB was STATindependent and appeared to be mediated by a 100 kDa complex binding to a CCAAT element. 19 Factors regulating the immediate response genes of the M1 cell differentiation program have not been well characterized. SKAP55R is a signaling adaptor protein expressed in hematopoietic cells. 20 In vitro studies suggested that SKAP55R was a substrate of the src-family of protein tyrosine kinases. 21 We have previously shown that SKAP55R was expressed predominantly in myeloid cells and its expression was rapidly induced in M1 cells treated with IL-6 or LIF. Furthermore, increased expression of SKAP55R was associated with myeloid cell growth arrest, a process intrinsically linked with macrophage differentiation. 20 In this study, we have examined the mechanism by which SKAP55R transcription is regulated by IL-6/LIF in M1 cells.
Materials and methods

Cell lines and reagents
Cell lines were obtained from ATCC and grown at 37°C in 5% CO 2 . The murine M1 myeloid leukemia cell line was maintained in Dulbecco's modified Eagle's medium with 10% fetal bovine serum and antibiotics (penicillin and streptomycin). The human 293 embryonal kidney cell line was maintained in Iscove's modified Dulbecco's medium with 10% fetal bovine serum and antibiotics. Recombinant mouse IL-6 and human LIF were purchased from Pharmingen (San Diego, CA, USA). Recombinant mouse LIF was purchased from Life Technologies (Rockville, MD, USA).
Northern blot analysis
Total RNA was isolated from M1 and 293 cells using TRIZOL Reagent (Life Technologies, Rockville, MD, USA). Ten g of RNA was electrophoresed on a 1% agarose gel containing 0.22 m formaldehyde, transferred to Hybond-N+ (Amersham Pharmacia, Pisscataway, NJ, USA) and hybridized in Church buffer at 65°C with [␣- 32 P]dCTP-labeled cDNA probes. Membranes were washed at 65°C in 2 × SSC 0.2% SDS and then exposed to Kodak XAR autoradiography film.
RNase protection assay
A DNA template for the RNase protection assay was generated by PCR using a 5Ј primer (5Ј-GGC TGA CAT ACC AGT AAC GA-3Ј) 416 nucleotides upstream of the start ATG and a 3Ј primer within intron 1 (5Ј-CGG TCT TCA TGA AAC-3Ј) 283 nucleotides downstream of the start ATG. The start ATG is 67 nt upstream of the exon/intron1 boundary. The PCR product was cloned into pCR2.1-TOPO (Invitrogen, Carlsbad, CA, USA), orientation confirmed by sequence analysis and then the plasmid was linearized 5Ј of the PCR product with BamHI. The template was purified by agarose gel electrophoresis. [␣- 32 P]CTP-labeled RNA probe was transcribed with the T7 primer using the MAXIscript in vitro transcription kit (Ambion, Austin, TX, USA). Hybridization of the probe and RNA (10 g) and RNase digestion were performed according to the standard procedure of the RPA II RNase protection assay kit (Ambion). Protected fragments were separated on an 8% nondenaturing polyacrylamide gel.
Reporter constructs
A mouse 129SvJ lambda genomic library (Stratagene, La Jolla, CA, USA) was screened by hybridization to a 21 bp oligonucleotide corresponding to the most 5Ј region of the murine SKAP55R cDNA (GenBank Acc No. AB014485). The promoter region was PCR-amplified using standard conditions and cloned into the reporter construct pGlow-TOPO (Invitrogen). The common 3Ј primer beginning at +40 with respect to the main transcription start site was 5Ј-CTC GCA ATA GCG GTC CGA G-3Ј. The 5Ј primers were 5Ј-GTA GCT CTG GTA GCG TCA TC-3Ј (−980GFP), 5Ј-GGC TGA CAT ACC AGT AAC GA-3Ј (−317GFP) and 5Ј-CAG AAA GCA AGG TCT ACG C-3Ј (−137GFP). Mutations in potential binding sites were created by PCR-site directed mutagenesis using sense and antisense oligonucleotides: CCAAT mutant 5Ј-GTC AGG TGA CAC AGC TCT GGC TCG CTC CCT TCC TT -3Ј; MZF-1a mutant 5Ј-GGT TTT AAG GCC GGT CTT TTT GCC CCT TCA CCC ATA GC-3Ј and MZF-1b mutant 5Ј-GCC CAA TTC TCC CGG GCT TTT AGG GGG CAG GGC CCG GC-3Ј (sense oligonucleotides are shown with the alteration from wild-type sequence underlined). All reporter constructs were sequenced.
Transfections pGlow-TOPO constructs (10 g) and pCMV-EBFP (1 g) as an internal control for transfection efficiency were transfected into 293 cells by the calcium-phosphate precipitation method. After 24 h, cells were harvested and replated in either saline or human LIF (1000 U/ml). Cells were then harvested after a Leukemia further 24 h and analyzed for GFP and BFP expression using a FACscan (Becton Dickinson, San Jose, CA, USA). Dead cells were excluded from analysis by staining with propidium idodide (1 g/ml). M1 cells were transfected with pGlow-TOPO constructs by electroporation (0.27 kV at 960 F). Transfected cells were selected by G418 (1 mg/ml) and then at least 24 independent pools of resistant clones were analyzed for GFP expression. Three clones with the highest GFP expression for each construct were used for subsequent analyses. Southern blot analyses using DNA from M1 cells was performed to confirm similar copy number for each reporter construct. Ten g of DNA was digested with BglII, DNA was run on a 1% agarose gel and transferred on to nylon membranes. Membranes were then probed with a 761 bp XbaI/PstI fragment from pGlow-TOPO.
Electrophoretic mobility shift assay (EMSA)
M1 and 293 cells were grown in saline or LIF (1000 U/ml) for 24 h. Nuclear extracts were prepared by hypotonic lysis followed by high salt extraction (420 mm KCl) of nuclei as previously described. 22 Complementary oligonucleotides with 5Ј GG overhangs (Table 1) 
Results
SKAP55R is an immediate response gene in M1 cells
The myeloid M1 leukemia cell line can be induced to differentiate into cells with a macrophage phenotype in response to IL-6 or LIF. 9 We have previously shown that mRNA levels of the src-kinase adaptor protein SKAP55R rapidly increased following exposure of M1 cells to IL-6 or LIF. 20 To confirm that the SKAP55R gene could be activated by IL-6/LIF in the absence of de novo protein synthesis, we examined the effect of LIF on mRNA SKAP55R levels in M1 cells pretreated with the protein synthesis inhibitor, cycloheximide. Consistent with other immediate-early response genes of myeloid differentiation, 11 SKAP55R mRNA levels increased rapidly even in the presence of cycloheximide ( Figure 1a ). Cycloheximide alone had no effect on mRNA SKAP55R levels (data not shown).
The SKAP55R promoter is LIF-responsive in M1 cells but not 293 cells
In order to understand the transcriptional regulation of mSKAP55R, we isolated a 16 kb genomic clone by hybridization to a 21 bp oligonucleotide corresponding to the most Table 1 Oligonucleotides used for EMSA 
The promoter region −317 to −137 contains the IL-6/LIF responsive element
To identify the start site of mSKAP55R, we performed 5Ј RACE and RNase protection using RNA isolated from M1 cells. Both methods of analysis revealed several start sites with a predominant site located 99 bp upstream of the ATG translation start codon (Figure 1b and data not shown) . Potential transcription factor binding sites within the 1.1 kb promoter sequence were identified using the MatInspector V2.2 program ( Figure 3) . Regulatory elements that might be involved in IL-6/LIF induction of SKAP55R included binding sites for STAT3 (−345 to −337), C/EBP (−305 to −293) and AP-1 (−316 to −307, −264 to −255, −144 to −134 and −117 to −107). In addition, there was a CCAAT element (−250 to −246) that was similar to a recently identified IL-6/LIF-responsive element of the junB promoter. 19 The SKAP55R promoter also contained two potential binding sites for the myeloid transcriptional regulator, MZF-1 (−92 to −85 and −53 to −46). This gene regulates in vitro expression of the CD34 promoter associated with myeloid differentiation. 24 To identify the IL-6/LIF response element(s), a series of 5Ј-deletion constructs were tested for LIF-responsive activity in M1 cells (Figure 4) . Deletion of sequences upstream of −317 (−317GFP) had no significant effect on the LIF response. The upstream region between −980 and −317 contained the putative STAT binding site. These data suggest that STAT binding was not required for the LIF-response of −317GFP, consistent with the lack of LIF response seen in 293 cells (Figure 2b ). M1 cells with the reporter construct −137GFP had significantly less promoter activity in unstimulated and LIFstimulated culture conditions compared with M1 cells containing −317GFP (P Ͻ 0.01). Indeed, −137GFP was not significantly different to control M1 cells transfected with −REV980GFP. This result suggested that a cis-acting element required for both basal and LIF-responsive activity was located between −317 and −137. This region contained potential binding sites for AP-1, C/EBP as well as the recently identified IL-6/LIF-responsive CCAAT element. The construct containing
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Figure 3
Proximal promoter sequence of SKAP55R. Potential regulatory elements are boxed. The predominant transcription start site (+1) indicated by the arrow was determined by RNase protection assay and 5Ј RACE. The positions of the 5Ј-deletions (−317 and −137) are shown. The coding region of exon 1 in bold and the initiation methionine (Met) are shown.
sequences −980 to −138 had no significant promoter activity. Thus, the downstream 137 bp sequence was necessary, but not sufficient for promoter activity. This region was GC rich (68%) and contained three potential Sp-1 binding sites, as well as the 2 MZF-1 sites (Figure 3 ).
The CCAAT element (−250 to −246) regulates IL-6/LIF-induced promoter activity
We examined the potential cis-acting elements lying within the −317 to −137 region by EMSA ( Figure 5 ). Nuclear extracts were prepared from unstimulated or LIF-treated M1 cells. Nuclear extracts incubated with a probe for Sp-1, a ubiquitous transcription factor, demonstrated similar loading in unstimulated and LIF-treated samples. Incubation with a STAT consensus probe demonstrated the formation of STAT3 homodimers in the presence of LIF, thus demonstrating the LIF-responsive nature of the M1 cells. A specific complex bound to the CCAAT probe was observed using both unstimulated and LIFstimulated nuclear extracts. The complex was two-fold more abundant using extracts made from LIF-treated cells (n = 3 experiments). A slightly faster migrating complex was demonstrated to be non-specific as the addition of unlabeled CCAAT oligonucleotide did not compete away this complex. Two specific complexes bound to the MZF-1 probe. There was no specific binding observed with the AP-1a, AP1b or C/EBP probes ( Figure 5 ).
Based on these data, we focused on the CCAAT and MZF-1 cis-acting elements. Constructs containing mutations of CCAAT or both MZF-1 binding sites were stably transfected in M1 cells. Mutation of both MZF-1 binding sites had no significant effect on basal or LIF-inducible promoter activity compared with the wild-type −980GFP promoter (Figure 6a ). In contrast, mutation of the CCAAT element significantly reduced promoter activity in both unstimulated and LIFstimulated culture conditions (P Ͻ 0.01). Mutation of the CCAAT element did not completely abolish LIF-inducible (Table 1 ) corresponding to the potential regulatory cis-acting elements present in the promoter region −317 to +40 were hybridized with nuclear lysates prepared from M1 cells grown in the absence or presence of LIF for 24 h. Competitor was 100-fold molar excess of unlabeled self-oligonucleotide. Probes made from Sp-1 and STAT consensus sequences were used as controls for equal loading (Sp-1) and LIF response (STAT). Arrows indicate complexes that could be competed by unlabeled competitor. activity (1.9-fold induction compared with 1.4-fold in the control −REV980GFP transfected cells).
To exclude the possibility that the results were due to reduced copies of reporter constructs in M1 cells, we performed Southern blot analysis of DNA prepared from M1 cells transfected with the different reporter constructs. Probing blots with a GFP cDNA demonstrated similar numbers of plasmid copies for the reduced activity promoters (−REV980, −137 and CCAAT mutant) compared with the responsive promoters (−980, −317 and MZF-1 mutant) (Figure 6a, data not shown) .
The CCAAT element is a low affinity NF-Y binding site
CCAAT is a common cis-acting element in many eukaryotic promoters. 25 NF-Y is the major protein complex recognizing the CCAAT element. 26 Previous in vitro DNA binding studies have demonstrated that nucleotide sequences immediately flanking the CCAAT element determined the affinity of NF-Y for DNA. 27 Although the flanking sequence of the SKAP55R promoter CCAAT element (gctCCAATtc) contained no matches with the ideal NF-Y binding consensus (c/a a/g a/g CCAATca), we tested an NF-Y antibody as well as an antibody against C/EBP␣ for their ability to super-shift the complex bound to the CCAAT element. The NF-Y antibody, but not the C/EBP␣ antibody super-shifted the complex bound to the CCAAT probe (Figure 7) . The complex was also competed effectively by unlabeled NF-Y consensus oligonucleotide.
Results of EMSA assays using a radiolabeled NF-Y consensus probe were consistent with the ability of the CCAAT probe to compete with an NF-Y consensus sequence (Figure 7 Using the NF-Y consensus sequence as probe, there was no difference in binding using extracts made from untreated or LIF-treated M1 or 293 cells (Figure 7) .
Recently, a CCAAT element of the junB promoter was shown to be critical for IL-6-induced activity. 19 This CCAAT Leukemia element is flanked by four of the five nucleotides found in the NF-Y consensus sequence. We tested for NF-Y binding to the junB CCAAT element by EMSA (Figure 8 ). Similar to the results seen with the CCAAT element of SKAP55R promoter, NF-Y but not C/EBP␣ antibody super-shifted the LIF-inducible complex.
Discussion
IL-6 and LIF signal through a shared receptor, gp130 dimerized to their specific receptor ␣-subunit. 28, 29 These cytokines have a wide range of biological effects in disease states such as acute sepsis and multiple myeloma. 1 Given the therapeutic importance of these cytokines, the identification of the immediate downstream targets of IL-6 and/or LIF has generated considerable interest. 12 In this study, we have demonstrated that the Src-kinase substrate adaptor SKAP55R is a member of a group of immediate response genes regulated by IL-6/LIF in M1 cells. M1 cells are a well-described model of LIF/IL-6 signaling and have a similar immediate gene response profile to primary cells. 11 Many of the genes identified as immediate response genes (IRF-1 and Gadd45 family members) are involved in growth suppression and apoptosis. 30, 31 Similarly, enforced expression of SKAP55R in primary hematopoietic cells also suggested a role in growth suppression. 20 The CCAAT element at position −250/−246 was important for both basal and IL-6/LIF-induced transcription of the SKAP55R gene in M1 cells. The CCAAT element was essential for basal promoter activity in M1 cells ( Figure 6 ). In contrast, mutation of the CCAAT element did not completely abolish LIF-inducible promoter activity. Thus, it is likely that other elements within the −317 to −137 region contribute to the LIFinduced transcription of SKAP55R. CCAAT elements are found in up to 30% of eukaryotic promoters. 25 Typically they are found within 100 nucleotides upstream of the transcription start site although there are examples of functionally important CCAAT elements further upstream. 32, 33 A CCAAT element was required for IL-6/LIF-induced transcription of another immediate response gene, junB in M1, but not HepG2 cells. 19 Unlike regulation of junB, we have also shown that the CCAAT element was important for basal transcription of SKAP55R. It is possible that Sjin et al 19 did not detect altered basal transcription of junB, because they used transient rather than stable transfection of M1 cells, and thus were measuring transcriptional activity of only a small proportion of M1 cells.
NF-Y is the major protein complex recognizing the CCAAT element. 26 The flanking nucleotides of the CCAAT element of the SKAP55R promoter are not typical for an NF-Y binding site based on previous in vitro experiments. 27 However, supershift and cold-competitor assays suggested that the SKAP55R CCAAT element could bind, albeit weakly, to NF-Y. NF-Y binding to the CCAAT element, but not to the NF-Y consensus was enhanced two-fold in extracts from LIF-treated M1 cells (Figure 7) . This difference in binding may be explained by the different flanking nucleotides of the two target sequences. NF-Y also appeared to bind to the CCAAT element of the junB promoter. Southwestern analysis of the CCAAT element of junB promoter revealed a 100-kDa protein complex. 19 This molecular weight is consistent with a NF-Y hetero-trimeric complex (40, 32 and 37 kDa). Our results are the first demonstration that NF-Y specifically mediates IL-6/LIF regulation of genes involved in M1 cell differentiation and growth arrest.
There are other examples of gene regulation by NF-Y in
Figure 7
The CCAAT element is a low affinity NF-Y binding site. EMSA using synthetic oligonucleotides made from the CCAAT element of SKAP55R promoter or an NF-Y consensus sequence. Nuclear extracts were prepared from M1 or 293 cells grown in the absence or presence of LIF for 24 h. Nuclear extracts were incubated for 1 h at 4°C with antibody prior to hybridization with labeled probe. mut, CCAAT mutant oligonucleotide.
Figure 8
NF-Y binds to the CCAAT element of junB promoter. EMSA using a synthetic oligonucleotide corresponding to the IL-6-responsive CCAAT element of the junB promoter. 19 Note the more prominent complex using nuclear extract from M1 cells cultured in the presence of LIF and the super-shift with NF-Y antibody, but not C/EBP␣ antibody. myeloid differentiation. For example, the IFN␥-induced upregulation of MHC class II on macrophages is mediated by NF-Y. 34 Expression of myeloperoxidase in a myeloid cell line treated with G-CSF was also mediated by NF-Y. 35 Given that NF-Y may regulate the transcription of two immediate response genes (SKAP55R and junB), it is possible that NF-Y regulates other immediate response genes that contain CCAAT elements. 19 If so, then NF-Y may be an attractive pharmacological target for modulation of the early downstream effects of IL-6/LIF. Recently, several anti-cancer drugs have been shown to inhibit binding of NF-Y to the CCAAT box. 36, 37 Although NF-Y is expressed ubiquitously, the effects of NF-Y inhibition may be more selective because gene regulation by NF-Y was cell-type specific.
The mechanism by which NF-Y regulates gene expression is unclear. One possibility is that NF-Y recruits other transcription factors to nearby binding sites. For example, NF-Y regulated the expression of albumin in response to serum by recruiting C/EBP to a nearby C/EBP binding site. 38 It is possible that NF-Y activity requires recruitment of another transcription factor to the −137 to +78 promoter region. This possibility is consistent with the observation that the −980 to −138 construct that contains the CCAAT element had no significant promoter activity (Figure 4 ). Our mutational analyses have excluded MZF-1, however we have not excluded other factors implicated in gene regulation, such as Sp-1 or AP-1. 39 AP-1 was shown to mediate the gp-130 cytokine, oncostatin Minduced expression of metalloproteinase-1. 16 Another mechanism of regulation by NF-Y is altered expression of the NF-Y A subunit. This appeared to be an important mechanism for the regulation of MHC class II, gp91-phox and the cdk inhibitor p27
Kip1 in myeloid differentiation. 40, 41 However, the upregulation of SKAP55R in the presence of cycloheximide argues against this mechanism. Another possibility would be post-translational modification of NF-Y. Phosphorylation of C/EBP has been demonstrated for IL-6-induced gene regulation of acute-phase reactants. 42 In summary, our studies suggest that NF-Y regulates the basal and IL-6/LIF-induced expression of two immediate response genes of myeloid differentiation, SKAP55R and junB. It remains to be determined whether NF-Y regulates other LIF/IL-6 immediate response genes in myeloid cells.
